Conserved steroid hormone homology converges on nuclear factor JB to modulate inflammation in asthma

Journal of Investigative Medicine

Volumn 60, Issue 1, 2012, Pages 13-17

  Payne, Asha S ^a,b   Freishtat, Robert J ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Asthma; Hormones; Inflammation; Nuclear factor JB

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SECOSTEROID; SEX HORMONE; STEROID HORMONE;

ASTHMA; CHEST TIGHTNESS; CONFERENCE PAPER; DYSPNEA; HORMONE ACTION; INFLAMMATION; WHEEZING;

EID: 84856756641     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31823d7989     Document Type: Conference Paper

References (60)

1. Deleted in proof.
2. Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985;318: 635-641. (Pubitemid 16172412)
3. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem. 1996;271: 9550-9559.
4. Leung DY, Hamid Q, Vottero A, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med. 1997;186: 1567-1574. (Pubitemid 27479816)
5. Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997;277: 1508-1510. (Pubitemid 27449239)
6. Richer JK, Jacobsen BM, Manning NG, et al. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem. 2002;277: 5209-5218. (Pubitemid 34968565)
7. Graham JD, Clarke CL. Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res. 2002;4: 187-190. (Pubitemid 34918996)
8. Sartorius CA, Melville MY, Hovland AR, et al. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol. 1994;8: 1347-1360. (Pubitemid 24335078)
9. Sunn KL, Cock TA, Crofts LA, et al. Novel N-terminal variant of human VDR. Mol Endocrinol. 2001;15: 1599-1609. (Pubitemid 32826412)
10. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am. 2010;39: 255-269, table of contents.
11. Bain DL, Heneghan AF, Connaghan-Jones KD, et al. Nuclear receptor structure: implications for function. Annu Rev Physiol. 2007;69: 201-220. (Pubitemid 46457641)
12. Morani A, Warner M, Gustafsson JA. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J Intern Med. 2008;264: 128-142. (Pubitemid 351962577)
13. Nicolaides NC, Galata Z, Kino T, et al. The human glucocorticoid receptor: molecular basis of biologic function. Steroids. 2010;75: 1-12.
14. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87: 905-931. (Pubitemid 47084672)
15. Zhou J, Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids. 2005;70: 407-417. (Pubitemid 40616039)
16. Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol. 2006;102: 11-21. (Pubitemid 44750633)
17. Picard D, Yamamoto KR. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 1987;6: 3333-3340.
18. Graupner G, Wills KN, Tzukerman M, et al. Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity. Nature. 1989;340: 653-656. (Pubitemid 19202577)
19. Pratt WB, Jolly DJ, Pratt DV, et al. A region in the steroid binding domain determines formation of the non-DNA-binding, 9 S glucocorticoid receptor complex. J Biol Chem. 1988;263: 267-273. (Pubitemid 18041074)
20. Webster NJ, Green S, Jin JR, et al. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell. 1988;54: 199-207.
21. Vegeto E, Allan GF, Schrader WT, et al. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell. 1992;69: 703-713.
22. Stahn C, Lowenberg M, Hommes DW, et al. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol. 2007;275: 71-78. (Pubitemid 47259281)
23. Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270: 286-290.
24. Hansdottir S, Monick MM, Lovan N, et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaBYlinked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184: 965-974.
25. Waterman WR, Xu LL, Tetradis S, et al. Glucocorticoid inhibits the human proYinterleukin lbeta gene (ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer. Mol Immunol. 2006;43: 773-782. (Pubitemid 41814394)
26. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med. 2003;139: 359-370. (Pubitemid 38124591)
27. Freishtat RJ, Watson AM, Benton AS, et al. Asthmatic airway epithelium is intrinsically inflammatory and mitotically dyssynchronous. Am J Respir Cell Mol Biol. 2011;44: 863-869.
28. Karin M, Yang-Yen HF, Chambard JC, et al. Various modes of gene regulation by nuclear receptors for steroid and thyroid hormones. Eur J Clin Pharmacol. 1993;45(suppl 1): S9-S15, discussion S43-S44. (Pubitemid 23341717)
29. Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 1990;62: 1189-1204.
30. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptorYsignaling pathways. Endocr Rev. 1999;20: 435-459. (Pubitemid 30648895)
31. Kushner PJ, Agard DA, Greene GL, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol. 2000;74: 311-317. (Pubitemid 32126243)
32. Porter W, Saville B, Hoivik D, et al. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol. 1997;11: 1569-1580. (Pubitemid 27435406)
33. Tseng L, Tang M, Wang Z, et al. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol. 2003;22: 633-640. (Pubitemid 37357733)
34. Cerillo G, Rees A, Manchanda N, et al. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol. 1998;67: 79-88. (Pubitemid 28547097)
35. Ray P, Ghosh SK, Zhang DH, et al. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett. 1997;409: 79-85. (Pubitemid 27248571)
36. Lu X, Farmer P, Rubin J, et al. Integration of the NFkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1, 25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem. 2004;92: 833-848. (Pubitemid 44264272)
37. Chung J, Koyama T, Ohsawa M, et al. 1, 25(OH)(2)D(3) blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-kappa;B. Lab Invest. 2007;87: 540-547. (Pubitemid 46788792)
38. Croxtall JD, Choudhury Q, Flower RJ. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol. 2000;130: 289-298. (Pubitemid 30261038)
39. Song RX, McPherson RA, Adam L, et al. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol Endocrinol. 2002;16: 116-127. (Pubitemid 34044502)
40. Rosenfeld CR, White RE, Roy T, et al. Calcium-activated potassium channels and nitric oxide coregulate estrogen-induced vasodilation. Am J Physiol Heart Circ Physiol. 2000;279: H319-H328. (Pubitemid 30616676)
41. Lange CA. Integration of progesterone receptor action with rapid signaling events in breast cancer models. J Steroid Biochem Mol Biol. 2008;108: 203-212. (Pubitemid 351179636)
42. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289: F8-F28.
43. MacLaughlin JA, Cantley LC, Holick MF. 1, 25(OH)2D3 increases calcium and phosphatidylinositol metabolism in differentiating cultured human keratinocytes. J Nutr Biochem. 1990;1: 81-87. (Pubitemid 20185075)
44. Barsony J, Marx SJ. Rapid accumulation of cyclic GMP near activated vitamin D receptors. Proc Natl Acad Sci U S A. 1991;88: 1436-1440. (Pubitemid 21916239)
45. Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids. 2002;67: 529-534. (Pubitemid 34311770)
46. Cato AC, Nestl A, Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE. 2002;2002: re9.
47. Salam MT, Wenten M, Gilliland FD. Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women. J Allergy Clin Immunol. 2006;117: 1001-1007.
48. Tantisira KG, Colvin R, Tonascia J, et al. Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med. 2008;178: 325-331.
49. Manfreda J, Sears MR, Becklake MR, et al. Geographic and gender variability in the prevalence of bronchial responsiveness in Canada. Chest. 2004;125: 1657-1664. (Pubitemid 38648394)
50. Forastiere F, Corbo G, Dell'Orco V, et al. A longitudinal evaluation of bronchial responsiveness to methacholine in children: role of baseline lung function, gender, and change in atopic status. Am J Respir Crit Care Med. 1996;153: 1098-1104.
51. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22: 470-477.
52. Chen Y, Stewart P, Johansen H, et al. Sex difference in hospitalization due to asthma in relation to age. J Clin Epidemiol. 2003;56: 180-187. (Pubitemid 36315945)
53. Ensom MH, Chong G, Beaudin B, et al. Estradiol in severe asthma with premenstrual worsening. Ann Pharmacother. 2003;37: 1610-1613. (Pubitemid 37315100)
54. Chandler MH, Schuldheisz S, Phillips BA, et al. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy. 1997;17: 224-234. (Pubitemid 27133346)
55. Matsuo N, Shimoda T, Matsuse H, et al. A case of menstruation-associated asthma: treatment with oral contraceptives. Chest. 1999;116: 252-253. (Pubitemid 29340292)
56. Lam SM, Huang SC. Premenstrual asthma: report of a case with hormonal studies. J Microbiol Immunol Infect. 1998;31: 197-199.
57. Mitchell VL, Gershwin LJ. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin Exp Allergy. 2007;37: 276-286. (Pubitemid 46148286)
58. Hellings PW, Vandekerckhove P, Claeys R, et al. Progesterone increases airway eosinophilia and hyper-responsiveness in a murine model of allergic asthma. Clin Exp Allergy. 2003;33: 1457-1463. (Pubitemid 37289945)
59. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol. 1998;12: 45-56. (Pubitemid 28124778)
60. Sutherland ER, Goleva E, Jackson LP, et al. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med. 2010;181: 699-704.